Raman Prakash
SEC insider (Form 3/4/5 filer). CIK 0002018686. Director at Black Diamond Therapeutics, Inc. (BDTX) and 1 other issuer. 14 reported Form 4/5 transactions since Sep 2024; latest on Sep 18, 2026. Located in CAMBRIDGE, MA.
Companies Raman Prakash has filed insider reports for
- Black Diamond Therapeutics, Inc. (BDTX): Director
- Olema Pharmaceuticals, Inc. (OLMA): Director
Raman Prakash
CIK: 0002018686
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Sep 18, 2026BDTX
Black Diamond Therapeutics, Inc.
AwardDirect6.8K shares at avg. $1.93$13K - Jun 26, 2026BDTX
Black Diamond Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
40K shares- - Jun 19, 2026BDTX
Black Diamond Therapeutics, Inc.
AwardDirect7.9K shares at avg. $1.66$13K - Jun 18, 2026OLMA
Olema Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
29.5K shares- - Apr 28, 2026OLMA
Olema Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
24.2K shares- - Apr 28, 2026OLMA
Olema Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
2.9K shares- - Mar 20, 2026BDTX
Black Diamond Therapeutics, Inc.
AwardDirect6.1K shares at avg. $2.15$13K - Dec 12, 2025BDTX
Black Diamond Therapeutics, Inc.
AwardDirect4.7K shares at avg. $2.76$13K - Sep 19, 2025BDTX
Black Diamond Therapeutics, Inc.
AwardDirect3.8K shares at avg. $3.35$13K - Jun 20, 2025BDTX
Black Diamond Therapeutics, Inc.
AwardDirect5.5K shares at avg. $2.33$13K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 18, 2026 |  BDTX Black Diamond Therapeutics, Inc. | Award | 6,801 | $1.93 | $13,126 | Direct |
| Jun 26, 2026 | BDTX Black Diamond Therapeutics, Inc. | Award Stock Option (Right to Buy) | 40,000 | - | - | Direct |
| Jun 19, 2026 | BDTX Black Diamond Therapeutics, Inc. | Award | 7,907 | $1.66 | $13,126 | Direct |
| Jun 18, 2026 |  OLMA Olema Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 29,500 | - | - | Direct |
| Apr 28, 2026 | OLMA Olema Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 24,150 | - | - | Direct |
| Apr 28, 2026 | OLMA Olema Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 2,911 | - | - | Direct |
| Mar 20, 2026 | BDTX Black Diamond Therapeutics, Inc. | Award | 6,105 | $2.15 | $13,126 | Direct |
| Dec 12, 2025 | BDTX Black Diamond Therapeutics, Inc. | Award | 4,665 | $2.76 | $12,875 | Direct |
| Sep 19, 2025 | BDTX Black Diamond Therapeutics, Inc. | Award | 3,843 | $3.35 | $12,874 | Direct |
| Jun 20, 2025 | BDTX Black Diamond Therapeutics, Inc. | Award | 5,526 | $2.33 | $12,876 | Direct |
1-10 of 14 transactions